Both the entities have entered into definitive agreements for the transaction involving a total consideration of Rs 1,872 crore. Panacea Bi...

Panacea said it expects to complete the transaction by the end of this year.

Panacea Biotec Pharma, a 100% subsidiary of Sputnik V Covid jab manufacturer Panacea Biotec, defaulted on payment of ₹114.67 crore includin...

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF, a joint ...

Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually.

Susheel Umesh brings in 27 years of experience, deep understanding of pharmaceutical industry, the company said. Panacea Biotec is a leadin...

In a statement, the fund said the deal involves an investment of Rs 864 crore into a forthcoming non-convertible debenture issue.

Panacea Biotec and builder Bestech Group to jointly develop a township project over a 100-acre plot owned by Panacea in Gurgaon.

Pharma firm Panacea Biotec today reported net loss of 62.28 crore for the third quarter ended December 31, 2012.

Panacea Biotec and Bestech will hold an equal stake in the project, which is expected to generate revenues of over Rs 1,500 crore.

To make the vaccine easily available, Panacea Biotec is partnering Emzor pharma which has a strong footprint across Nigeria.

A leading Indian pharmaceutical company has launched a polio vaccine, POLPROTEC in Nigeria to help combat the spread of polio in Africa's t...

Panacea Biotec will soon launch a generic version of Abraxis Bioscience's breast cancer medicine Abraxane at half the price of the original...

In a chat with ET Now, Seshadri Bharathan, MD & CEO, KSEMA Fincon Ltd., talks about the outlook of the mid-cap pharma stocks.

India’s largest vaccine maker, Serum Institute of India, has picked up close to 7% stake in rival firm Panacea Biotec.

Vaccine manufacturer Panacea Biotec on Wednesday said it has entered into a strategic alliance with US-based PharmAthene and will invest 13...

Vaccine maker Panacea Biotec is foraying into the hospital business by setting up a 220-bed multi-specialty hospital with Gurgaon-based Umk...